OrthoSpin receives US FDA approval for smart, robotic external fixation system for orthopaedic treatments

OrthoSpin Ltd, a portfolio company of The Trendlines Group Ltd. (Trendlines), announced that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its smart, robotic external fixation system for orthopaedic treatments. Today, the use of external fixation is a common treatment option for orthopaedic-related problems: bone lengthening, setting complex fractures, and correcting deformities. The two main challenges associated with these systems are patient compliance and lack of real-time feedback for the physician. External fixation requires the patient to make multiple manual adjustments every day. This requires significant patient training and involvement and can lead to errors. Many times, the patient does not fully or precisely comply with the mechanical adjustments, which results in less than optimal clinical outcomes.

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.001255 seconds